DAWN Stock-Based Compensation
Day One Biopharmaceuticals Inc · Stock-Based Compensation
DAWN Stock-Based Compensation
Latest reported$44.39Mperiod ending
DAWN FY Stock-Based Comp ($111.00K → $44.39M)
Annual stock-based compensation
High-resolution chart · PNG
DAWN stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 44,388,000 | |
| 48,263,000 | |
| 39,341,000 | |
| 27,242,000 | |
| 13,321,000 | |
| 526,000 | |
| 111,000 |